Fulvene and fulvalene analogs and their use in treating cancers

Details for Australian Patent Application No. 2008247544 (hide)

International Classifications

Event Publications

26 November 2009 PCT application entered the National Phase

PCT publication WO2008/137740 Priority application(s): WO2008/137740

10 December 2009 Amendment Made

The nature of the amendment is: Amend the priority details to add US 12/114,601 02 May 2008

10 December 2009 Assignment before Grant

Emory University The application has been assigned to Emory University; The U.S Government as Represented by the Department of Veterans Affairs

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.